Home / State Laws / Ohio

Are peptides legal in Ohio?

Short answer: Peptides such as BPC-157, TB-500, and research-grade GLP-1 compounds are not addressed by any Ohio-specific statute or Board of Pharmacy rule naming them as a distinct category, so their legality in Ohio defaults to the general federal/state drug-approval and pharmacy-compounding framework rather than a peptide-specific state law.

Legal Status Overview

Gray Area

Ohio has no identified statute, administrative code section, or Board of Pharmacy rule that singles out "peptides" or "research chemicals" as their own regulatory category; the state instead regulates these substances through its general drug, pharmacy-practice, and compounding laws. Under that general framework, a peptide that is an FDA-approved drug (e.g., semaglutide/tirzepatide as Ozempic, Wegovy, Mounjaro, Zepbound) is legal only with a valid prescription dispensed through a licensed pharmacy, while unapproved "research use only" peptides (BPC-157, TB-500, many HGH-related peptides) fall into a legal gray zone where they are not scheduled as controlled substances but also are not approved by FDA for human use, making their marketing for human consumption potentially unlawful under federal drug-misbranding rules even absent an Ohio-specific ban. This record should be treated as a starting point for further verification rather than a definitive legal conclusion, because confirmation searches specifically for Ohio-specific peptide/research-chemical provisions could not be completed live in this session.

Key Points

  • No Ohio statute or Ohio Administrative Code provision naming "peptides" or "research chemicals" as a distinct legal category has been identified; peptides are governed by Ohio's general pharmacy-practice and compounding rules instead. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
  • The Ohio Board of Pharmacy is the primary state agency that licenses pharmacies, enforces compounding standards, and regulates dispensing of prescription drugs in Ohio, including any compounded peptide-based medications. [1]
  • Compounded drugs made or dispensed in Ohio, including compounded semaglutide/tirzepatide-type or peptide preparations, must comply with Ohio Administrative Code compounding rules that are built on the federal 503A (traditional pharmacy compounding) and 503B (outsourcing facility) framework established by the Drug Quality and Security Act. [2]

Sources

Last researched: 2026-10-02

Enforcement & Compliance

Note: This page provides general information based on the sourced research above. For specific legal questions in Ohio, consult with a licensed attorney familiar with pharmaceutical law.